Conference abstract · 31 Oct 2018
Conference abstractPublished 7 Sep 2016
Artemisinin protected neuronal cells from oxidative insult via the MAPK pathway
University of Macau, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Artemisinin, also known as Qinghao su, isolated from Artemisia annua, is a drug that possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is clinically safe, potent and effective in human. At present study, we found that artemisinin promoted the survival of various cell types such as PC12 cells and primary cortical cultured neurons from oxidative insults. For example, pretreatment of PC12 cells with artemisinin significantly suppressed SNP/H2O2-induced cell death by decreasing the production of intracellular reactive oxygen species (ROS), preventing the decline of mitochondrial membrane potential, restoring abnormal changes in nuclear morphology and reducing LDH and caspase 3/7 activities. Western blotting analysis showed that artemisinin was able to stimulate the phosphorylation/activation of extracellular regulated protein kinases (ERK) kinase and CREB while had no effect on the Akt pathway. In addition, ERK signaling pathway inhibitor PD98059 blocked the protective effect of artemisinin whereas the PI3K inhibitor LY294002 had no effect. Taken together, these results suggest that artemisinin as a potential neuroprotectant is able to suppress various oxidative stress-induced neuronal cell deaths via the activation of ERK signaling. Our results offer support for the potential development of artemisinin to prevent neuronal degenerative disorders.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Jun 2018
AS-6 suppresses lipopolysaccharide–induced neuroinflammation in BV2 microglial cells via inhibition of NF-κB and MAPK pathway
Research article · 31 Dec 2017
Mesuaferrin-A: Bio Active Flavonoid Inhibits LPS Stimulated Inflammatory Response via Down-Regulation of NF-κB and MAPK Signaling Pathways in RAW 264.7 Cell Lines
Review article · 2020
CDDO Me Provides Kidney Protective Impacts against Ischemia/Reperfusion Injury via Inhibition of Oxidative Stress and Inflammation by Targeting Nrf2 and NF-kB Signaling Pathways
Conference abstract · 16 Nov 2015
Protection of neuron cells from apoptosis by Korean red ginseng via ERÃ?²/PI3K signaling
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Wenhua Zheng”
- BylineArticles whose byline prints “Fang Jiankang”
- BylineArticles whose byline prints “Wan Pei”
- BylineArticles whose byline prints “Xu Jinying”
- BylineArticles whose byline prints “Cheong-Meng Chong”
- BylineArticles whose byline prints “Philip Lazarovici”
